Cryogenic Solutions Inc. (CYGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DOC who wrote (1831)	7/22/1998 8:26:00 PM
From: Cavalry	Read Replies (2) of 4028

huge step forward for antisense see this release BETHESDA, Md., July 22 (Reuters) - The first in an entirely new class of biotech drugs called "antisense" compounds got the backing of federal advisers Wednesday. The 5-2 vote of confidence means the drug, Isis Pharmaceuticals <ISIP.O> Vitravene (fomivirsen), could be approved by the U.S. Food and Drug Administration (FDA) within months, since it is on a fast track review. Vitravene was recommended for both newly diagnosed cytomegalovirus (CMV) retinitis or CMV retinitis that has not responded to available drugs. The viral infection hits AIDS patients in the late stages of the disease and can cause blindness. 5-2 vote didn't squeak by, first approval for antisense. Cav

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next